-- Preview Email Newsletter
| Journals Medical Newsletter for 2026-07-26 ( 3 items ) |
|
Glioblastoma Approach Shows Promise in Early Testing (10)
CHARLOTTESVILLE, Virginia, July 24 -- University of Virginia Health posted the following news release:
* * *
Glioblastoma Approach Shows Promise in Early Testing
*
University of Virginia Comprehensive Cancer Center scientists have developed a promising new experimental approach to targeting glioblastoma, the most common and deadliest brain cancer. The approach could overcome many of the limitations of treatments using existing drugs.
UVA's Roger Abounader, MD, PhD, and colleagues have identified "microRNAs" that can simultaneously suppres more PR
New Treatment Approach Improves Survival and Reduces Recurrence Risk for Patients With Muscle-Invasive Bladder Cancer (10)
NEW YORK, July 24 [Category: BizHospital] -- Mount Sinai Health System posted the following news release:
* * *
New Treatment Approach Improves Survival and Reduces Recurrence Risk for Patients With Muscle-Invasive Bladder Cancer
*
Researchers have found that a combination of enfortumab vedotin and pembrolizumab helps patients with muscle-invasive bladder cancer live longer while reducing the risk that their cancer will return after surgery, according to an international phase 3 clinical trial published in The New England Journal of Medicin more PR
Secretary of State Rubio Addresses Global Flashpoints in Manila, Covering Ukraine Peace Efforts, Iran Strategy, Philippine Ties (10)
WASHINGTON, July 25 -- The U.S. State Department issued the following transcript of a news conference by Secretary Marco Rubio at the Philippine International Convention Center highlighting U.S. willingness to broker a peace deal in Ukraine while fielding questions on escalating strikes against Iran and reaffirming defense ties with regional allies in the Indo-Pacific:
* * *
Secretary of State Marco Rubio Remarks to the Press
SECRETARY RUBIO: All right, what's up?
QUESTION: Have you made any progress on Ukraine today? Is Russia serious abo more PR
|
